Eric Heil
InvestorManaging Partner at Medical Excellence Capital
Pennsylvania
Writes $100K – $5M checks · typically $1.5M
About
Eric Heil is a five-time founder and CEO who simultaneously runs companies—currently CEO of Ladder Bio—while co-founding biotech startups and spinning out platforms like ProJenX and RightCare through his fund.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Experience
- Medical Excellence Capital, LLCManaging Partnercurrent2021 — presentDoylestown, Pennsylvania, United States
- Ladder Bio Inc.Chief Executive Officercurrent2025 — present
- GC TherapeuticsBoard Observercurrent2023 — present
- ProJenX, Inc.Chair & Board Member (Served as interim founding CEO)current2021 — present
- Nobias TherapeuticsBoard Membercurrent2021 — present
- Health Quality Partners (HQP)SVP, Global Growth & Opportunity2019 — 2021Doylestown, PA
- The Wharton SchoolAdjunct Professor/Co-Instructor - Healthcare Entrepreneurship2016 — 2020Philadelphia, PA
- Upward HealthCofounder & Interim Founding CEO2017 — 2018Doylestown, Pennsylvania, United States
- naviHealthSVP, Chief Commercial Officer Software Solutions2015 — 2017Horsham, PA
- RightCare SolutionsCo-founder, President & CEO2011 — 2015Greater Philadelphia Area
- Domain AssociatesEntrepreneur In Residence / Portfolio Company CEO2012 — 2014
- Domain AssociatesVenture Capital Associate2011 — 2012Princeton, NJ
- Domain AssociatesVenture Capital Analyst2008 — 2010Princeton, NJ
- Celator PharmaceuticalsSenior Director, Business Development2010 — 2012Princeton, NJ
- Corthera, Inc.Director, Business Development2008 — 2009San Mateo, CA
- Bear Stearns & Co.Equity Research Associate - Managed Care2007 — 2008New York, New York
- Easton AssociatesResearch Associate2005 — 2006New York, NY
- Independence Blue CrossIntern2004Philadelphia, PA
Education
- The Wharton SchoolMBA, MBA for Executives2010 — 2012
- University of PennsylvaniaBSE, Systems Engineering2002 — 2005
- Lehigh UniversityBSE Candidate, Computer Engineering2001 — 2002
Skills & more
Board of Directors11CEOs9StartupsBusiness Planning3Venture Capital99Portfolio Management18Equity Research5Corporate Development32Mergers4Pharmaceuticals3Healthcare39Valuation13
+12 more
BiotechnologyEntrepreneurshipBusiness DevelopmentMergers & AcquisitionsBusiness StrategyStart-upsInvestmentsPrivate EquityPharmaceutical IndustryStrategyManagementLeadership- Series 63 — Bear Stearns Companies
- Series 7 — Bear Stearns Companies
- Venture Capital — Wharton Executive Education
From Eric's professional profile.
Same school
Also attended The Wharton School1,323
Fred WilsonCo-founder & Partner at Union Square VenturesJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General CatalystRebecca JamesInvestor at Index Ventures
+ 1,317 more
Also attended University of Pennsylvania607
Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark CapitalKerry KilleenAssociate General Counsel at Revolution
+ 601 more
Also attended Lehigh University54
Joseph R. SavianoFounder and Managing Member at Dot CapitalStuart SchnabolkChief Financial Officer at Ibex InvestorsJay FraserInvestor at Side Door VenturesMegan CainPrincipal at The Westly GroupSam GerouxAnalyst, Data at StripesMatt VineSenior Associate at RRE Ventures
+ 48 more
Shared employers
Also worked at Health Quality Partners (HQP)1
Also worked at Upward Health4
Also worked at naviHealth4
Also worked at Easton Associates3
Deals · 1
Rejuvitas, Inc.Board seat
via Medical Excellence Capital · filed Sep 2022 · $5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Medical Excellence Capital
Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brad Ringeisen
Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital
Brian Halak
Managing Partner at Medical Excellence Capital
Douglas Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Gregg Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
John Hornbostel
Counsel at Medical Excellence Capital
John Prufeta
Chief Executive Officer and Managing Partner at Medical Excellence Capital
Joni Mancini
Managing Partner at Medical Excellence Capital
Network1
Investors connected to Eric in public investor directories — a warm-intro map.



.jpeg)





























